Revashnee Naidoo

456 citations
7 papers · 181 indexed · h-index 4
Topics
CAR-T cell therapy research (4 papers)Immunotherapy and Immune Responses (4 papers)Ocular Oncology and Treatments (4 papers)
Journals
SHILAP Revista de lepidopterologíaCancer ResearchClinical Cancer Research

In The Last Decade

Revashnee Naidoo

7 papers receiving 174 citations

Peers

Revashnee Naidoo
Comparison fields: 5 of 30
  • Immunology 123
  • Oncology 111
  • Ophthalmology 73
  • Molecular Biology 47
  • Radiology, Nuclear Medicine and Imaging 40
Replace Cheryl McAlpine with:
Cheryl McAlpine United States
Thomas Jouary France
Emma Sangalang United States
Jennifer Johnston United States
Rachel L. Davis United States
Andrew Furness United Kingdom
Virpi Raivio Finland
Joanna E. Brewer United Kingdom
Charles B. Trelford Canada
Alexandra Jacquet France
Revashnee Naidoo relative to Cheryl McAlpine United States Cheryl McAlpine's profile →
Citations per field
00.5×1.5×
Cheryl McAlpine · 1×
Citations per year

Countries citing papers authored by Revashnee Naidoo

Since Specialization
Citations

This map shows the geographic impact of Revashnee Naidoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Revashnee Naidoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Revashnee Naidoo more than expected).

Fields of papers citing papers by Revashnee Naidoo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Revashnee Naidoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Revashnee Naidoo. The network helps show where Revashnee Naidoo may publish in the future.

Co-authorship network of co-authors of Revashnee Naidoo

This figure shows the co-authorship network connecting the top 25 collaborators of Revashnee Naidoo. A scholar is included among the top collaborators of Revashnee Naidoo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Revashnee Naidoo. Revashnee Naidoo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 1
2 1
3 3
4 3
5 3
6 5
7 165

About Revashnee Naidoo

Revashnee Naidoo is a scholar working on Ophthalmology, Immunology and Oncology, having authored 7 papers that have together received 181 indexed citations. Recurring topics across this work include CAR-T cell therapy research (4 papers), Immunotherapy and Immune Responses (4 papers) and Ocular Oncology and Treatments (4 papers). The work is most often cited by research in Ophthalmology (73 citations), Immunology (123 citations) and Oncology (111 citations). Revashnee Naidoo has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Emma Leach, Cheryl McAlpine, Pippa Corrie, Alan Anthoney, Omid Hamid, Avinash Gupta, Neil Steven, T.R. Jeffry Evans, Sion Lewis and Mario Sznol. Their work appears in journals such as SHILAP Revista de lepidopterología, Cancer Research and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026